COVID-19, cytokines, inflammation, and spices: How are they related?
Background Cytokine storm is the exaggerated immune response often observed in viral
infections. It is also intimately linked with the progression of COVID-19 disease as well as …
infections. It is also intimately linked with the progression of COVID-19 disease as well as …
Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2
Despite tremendous efforts in the past two years, our understanding of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …
VDA-RWLRLS: An anti-SARS-CoV-2 drug prioritizing framework combining an unbalanced bi-random walk and Laplacian regularized least squares
L Shen, F Liu, L Huang, G Liu, L Zhou… - Computers in biology and …, 2022 - Elsevier
Background A new coronavirus disease named COVID-19, caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), is rapidly spreading worldwide …
respiratory syndrome coronavirus-2 (SARS-CoV-2), is rapidly spreading worldwide …
[HTML][HTML] Multi-epitope vaccine for monkeypox using pan-genome and reverse vaccinology approaches
Outbreaks of monkeypox virus infections have imposed major health concerns worldwide,
with high morbidity threats to children and immunocompromised adults. Although …
with high morbidity threats to children and immunocompromised adults. Although …
A comprehensive review on genomics, systems biology and structural biology approaches for combating antimicrobial resistance in ESKAPE pathogens …
In recent decades, antimicrobial resistance has been augmented as a global concern to
public health owing to the global spread of multidrug-resistant strains from different ESKAPE …
public health owing to the global spread of multidrug-resistant strains from different ESKAPE …
MurC ligase of multi-drug resistant Salmonella Typhi can be inhibited by novel curcumin derivative: evidence from molecular docking and dynamics simulations
Emerging multi-drug resistance in recent Salmonella Typhi isolates, causative agent of
enteric Typhoid fever, compelled us to investigate alternative therapeutic strategies. The …
enteric Typhoid fever, compelled us to investigate alternative therapeutic strategies. The …
[HTML][HTML] An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2
F Yan, F Gao - Computational and structural biotechnology journal, 2021 - Elsevier
There is an urgent need to develop effective treatments for coronavirus disease 2019
(COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS …
(COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS …
Identification of bioactive natural compounds as efficient inhibitors against Mycobacterium tuberculosis protein-targets: a molecular docking and molecular dynamics …
Mycobacterium tuberculosis (Mtb), the etiological agent of tuberculosis (TB), imposes a
significantly high morbidity threat to humans in both developed and developing nations. The …
significantly high morbidity threat to humans in both developed and developing nations. The …
In silico structure evaluation of BAG3 and elucidating its association with bacterial infections through protein–protein and host‐pathogen interaction analysis
BAG3, a co‐chaperone protein with a Bcl‐2‐associated athanogene (BAG) domain, has
diverse functionalities in protein‐folding, apoptosis, inflammation, and cell cycle regulatory …
diverse functionalities in protein‐folding, apoptosis, inflammation, and cell cycle regulatory …
[HTML][HTML] Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations
SE Omer, TM Ibrahim, OA Krar, AM Ali, AA Makki… - … and biophysics reports, 2022 - Elsevier
The current novel corona virus illness (COVID-19) is a developing viral disease that was
discovered in 2019. There is currently no viable therapeutic strategy for this illness …
discovered in 2019. There is currently no viable therapeutic strategy for this illness …